Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 22 01:04PM ET
Dollar change
Percentage change
IndexRUT P/E14.75 EPS (ttm)2.45 Insider Own5.55% Shs Outstand57.71M Perf Week-1.71%
Market Cap2.12B Forward P/E- EPS next Y-1.41 Insider Trans-4.02% Shs Float55.40M Perf Month14.92%
Income162.11M PEG- EPS next Q-0.60 Inst Own99.10% Short Float3.68% Perf Quarter41.04%
Sales314.95M P/S6.73 EPS this Y220.33% Inst Trans-9.30% Short Ratio2.28 Perf Half Y45.82%
Book/sh9.56 P/B3.78 EPS next Y-184.59% ROA37.30% Short Interest2.04M Perf Year81.51%
Cash/sh5.50 P/C6.57 EPS next 5Y- ROE41.75% 52W Range13.72 - 38.03 Perf YTD57.52%
Dividend Est.- P/FCF- EPS past 5Y4.38% ROI28.93% 52W High-5.01% Beta2.12
Dividend TTM- Quick Ratio15.72 Sales past 5Y2462.45% Gross Margin98.95% 52W Low163.27% ATR (14)1.35
Dividend Ex-Date- Current Ratio15.72 EPS Y/Y TTM191.97% Oper. Margin47.21% RSI (14)59.69 Volatility3.35% 3.74%
Employees112 Debt/Eq0.00 Sales Y/Y TTM36565.08% Profit Margin51.47% Recom1.17 Target Price43.83
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q588.87% Payout- Rel Volume0.18 Prev Close35.55
Sales Surprise-2.88% EPS Surprise-3.17% Sales Q/Q- EarningsMay 08 AMC Avg Volume895.47K Price36.12
SMA204.71% SMA5011.26% SMA20042.02% Trades Volume94,265 Change1.60%
Date Action Analyst Rating Change Price Target Change
Oct-30-23Initiated CapitalOne Overweight $32
May-25-23Resumed Jefferies Buy $30 → $40
Aug-25-22Initiated JMP Securities Mkt Outperform $21
Feb-11-22Initiated BTIG Research Buy $55
Oct-12-21Upgrade JP Morgan Neutral → Overweight $49 → $55
Oct-11-21Upgrade Northland Capital Market Perform → Outperform $40
Sep-20-21Downgrade JP Morgan Overweight → Neutral $60 → $49
May-24-21Initiated Northland Capital Outperform $42
May-24-21Initiated JMP Securities Mkt Outperform $48
Jan-06-21Initiated JP Morgan Overweight
Today 07:00AM
Jul-18-24 08:50AM
Jul-11-24 06:00AM
Jun-28-24 04:07PM
05:44PM Loading…
Jun-27-24 05:44PM
Jun-26-24 10:12PM
Jun-14-24 03:00AM
Jun-05-24 01:35PM
May-31-24 07:30AM
May-14-24 04:05PM
May-07-24 11:53PM
04:10PM Loading…
Apr-16-24 09:00AM
Apr-05-24 12:00PM
Apr-03-24 01:52AM
Mar-26-24 07:00AM
Mar-18-24 09:55AM
Mar-11-24 07:00AM
Mar-06-24 04:05PM
Mar-01-24 12:20PM
04:38PM Loading…
Feb-27-24 04:38PM
Feb-21-24 05:00PM
Feb-20-24 04:05PM
Feb-15-24 03:13AM
Feb-07-24 05:00PM
Feb-02-24 01:03PM
Feb-01-24 06:35AM
Jan-31-24 04:05PM
Jan-29-24 07:30AM
Jan-12-24 03:02AM
Jan-03-24 07:30AM
Dec-16-23 11:01AM
Dec-13-23 07:30AM
Dec-12-23 09:04AM
Nov-27-23 09:00AM
Nov-16-23 04:05PM
Nov-09-23 03:55PM
Nov-04-23 05:42AM
Nov-02-23 06:24PM
Nov-01-23 04:05PM
Oct-30-23 04:05PM
Oct-09-23 07:00AM
Oct-03-23 04:05PM
Sep-05-23 07:30AM
Aug-16-23 04:05PM
Aug-09-23 07:00AM
Aug-03-23 04:48PM
Jul-18-23 04:05PM
Jul-05-23 09:33AM
Jul-04-23 03:30AM
Jun-30-23 08:50AM
Jun-15-23 09:55AM
Jun-13-23 08:50AM
Jun-09-23 08:05AM
Jun-06-23 07:30AM
Jun-01-23 04:01PM
May-26-23 09:55AM
May-12-23 03:14PM
May-11-23 04:05PM
May-05-23 04:03PM
May-04-23 05:02PM
Apr-20-23 09:51PM
Apr-17-23 06:35AM
Apr-04-23 10:45PM
Mar-21-23 03:49AM
Mar-20-23 06:08AM
Mar-17-23 06:06AM
Mar-15-23 04:01PM
Mar-09-23 11:14AM
Mar-08-23 12:19PM
Mar-07-23 11:54AM
Jan-25-23 03:24AM
Jan-14-23 07:14AM
Dec-21-22 04:05PM
Dec-05-22 09:55AM
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Waddill William D.DirectorJun 07 '24Option Exercise12.888,000103,04020,000Jun 11 04:30 PM
PATEL DINESH V PH DPresident and CEOJun 07 '24Sale35.1935,0001,231,650515,415Jun 11 04:30 PM
Waddill William D.DirectorJun 07 '24Sale35.008,000280,00012,000Jun 11 04:30 PM
Ali AsifChief Financial OfficerApr 18 '24Sale25.111,23430,98637,163Apr 19 08:05 PM
PATEL DINESH V PH DPresident and CEOApr 01 '24Sale28.3125,000707,750549,590Apr 02 08:29 PM
SELICK HAROLD EDirectorMar 07 '24Option Exercise1.896,49012,26627,996Mar 11 08:00 PM
Ali AsifChief Financial OfficerMar 01 '24Option Exercise12.1712,000146,04052,645Mar 01 08:45 PM
Waddill William D.DirectorMar 01 '24Option Exercise6.0912,97579,01824,975Mar 01 08:45 PM
PATEL DINESH V PH DPresident and CEOMar 01 '24Sale31.6230,000948,600574,590Mar 01 08:46 PM
Ali AsifChief Financial OfficerMar 01 '24Sale32.2414,248459,31838,397Mar 01 08:45 PM
Waddill William D.DirectorMar 01 '24Sale31.3412,975406,63612,000Mar 01 08:45 PM
Ali AsifChief Financial OfficerFeb 29 '24Sale30.699,939305,04840,645Mar 01 08:45 PM
Gupta SuneelChief Development OfficerJan 09 '24Option Exercise7.385,00036,900192,567Jan 11 08:00 PM
Gupta SuneelChief Development OfficerJan 09 '24Sale25.005,000125,000187,567Jan 11 08:00 PM
PATEL DINESH V PH DPresident and CEODec 13 '23Sale20.0875,0001,506,000534,347Dec 15 04:30 PM
MOLINA ARTURO MDChief Medical OfficerNov 15 '23Sale16.241,84830,01222,527Jan 04 08:09 PM
Gupta SuneelChief Development OfficerOct 19 '23Option Exercise7.3820,000147,600168,317Oct 23 04:31 PM
PATEL DINESH V PH DPresident and CEOOct 18 '23Option Exercise4.216,00025,260609,347Oct 19 04:55 PM